373 related articles for article (PubMed ID: 21943815)
21. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
[TBL] [Abstract][Full Text] [Related]
22. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
Lai MC; Kuo YC; Kuo HC
Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
[TBL] [Abstract][Full Text] [Related]
23. Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis.
Aghamir SM; Mohseni MG; Arasteh S
Urol J; 2007; 4(1):18-23. PubMed ID: 17514606
[TBL] [Abstract][Full Text] [Related]
24. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
25. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
26. The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results.
Daha LK; Lazar D; Simak R; Pflüger H
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):987-90. PubMed ID: 18227956
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
Bosch PC
J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
[TBL] [Abstract][Full Text] [Related]
28. Improvement in sexual functioning in patients with interstitial cystitis/painful bladder syndrome.
Nickel JC; Parsons CL; Forrest J; Kaufman D; Evans R; Chen A; Wan G; Xiao X
J Sex Med; 2008 Feb; 5(2):394-9. PubMed ID: 18086174
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.
Nickel JC; Barkin J; Forrest J; Mosbaugh PG; Hernandez-Graulau J; Kaufman D; Lloyd K; Evans RJ; Parsons CL; Atkinson LE;
Urology; 2005 Apr; 65(4):654-8. PubMed ID: 15833501
[TBL] [Abstract][Full Text] [Related]
30. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
[TBL] [Abstract][Full Text] [Related]
32. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction.
Sand PK; Kaufman DM; Evans RJ; Zhang HF; Alan Fisher DL; Nickel JC
Curr Med Res Opin; 2008 Aug; 24(8):2259-64. PubMed ID: 18582395
[TBL] [Abstract][Full Text] [Related]
33. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
Dawson TE; Jamison J
Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
[TBL] [Abstract][Full Text] [Related]
34. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis.
van Ophoven A; Heinecke A; Hertle L
Urology; 2005 Oct; 66(4):707-11. PubMed ID: 16230121
[TBL] [Abstract][Full Text] [Related]
36. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions.
Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B
Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171
[TBL] [Abstract][Full Text] [Related]
37. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
Mayer R; Propert KJ; Peters KM; Payne CK; Zhang Y; Burks D; Culkin DJ; Diokno A; Hanno P; Landis JR; Madigan R; Messing EM; Nickel JC; Sant GR; Warren J; Wein AJ; Kusek JW; Nyberg LM; Foster HE;
J Urol; 2005 Apr; 173(4):1186-91. PubMed ID: 15758738
[TBL] [Abstract][Full Text] [Related]
40. Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.
Matsumoto S; Ueda T; Kakizaki H
Urology; 2013 Feb; 81(2):226-30. PubMed ID: 23374763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
